Consolidated Statement of Stockholders' Equity (Deficit) (OWP Ventures, Inc.) - USD ($) |
OWP Ventures, Inc. [Member]
Common Stock [Member]
|
OWP Ventures, Inc. [Member]
Additional Paid-In Capital [Member]
|
OWP Ventures, Inc. [Member]
Subscriptions Receivable [Member]
|
OWP Ventures, Inc. [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
|
OWP Ventures, Inc. [Member]
Accumulated Deficit [Member]
|
OWP Ventures, Inc. [Member]
Noncontrolling Interest [Member]
|
OWP Ventures, Inc. [Member] |
Common Stock [Member] |
Additional Paid-In Capital [Member] |
Subscriptions Receivable [Member] |
Accumulated Other Comprehensive Income (Loss) [Member] |
Accumulated Deficit [Member] |
Noncontrolling Interest [Member] |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Mar. 26, 2018 | ||||||||||||||
| Balance, shares at Mar. 26, 2018 | ||||||||||||||
| Consolidation of One World Pharma, Inc. | (349,420) | $ (349,420) | (349,420) | |||||||||||
| Common stock sold for cash | $ 2,341 | 999,774 | (602) | $ 23,412 | 978,703 | (602) | 1,001,513 | |||||||
| Common stock sold for cash, shares | 23,411,905 | 23,411,905 | ||||||||||||
| Common stock issued for services | $ 68 | 285,532 | $ 680 | 284,920 | 285,600 | |||||||||
| Common stock issued for services, shares | 680,000 | 680,000 | ||||||||||||
| Common stock issued for purchase of One World Pharma S.A.S. | $ 1,020 | 161,889 | $ 10,200 | 152,709 | 162,909 | |||||||||
| Common stock issued for purchase of One World Pharma S.A.S., shares | 10,200,000 | 10,200,000 | ||||||||||||
| Contributed capital | 136,440 | 136,440 | 136,440 | |||||||||||
| Beneficial conversion feature on convertible note | 75,000 | 75,000 | 75,000 | |||||||||||
| Loss on foreign currency translation | (4,090) | (4,090) | (4,090) | |||||||||||
| Net loss | (1,959,982) | (101) | (1,959,982) | (101) | (1,960,083) | |||||||||
| Balance at Dec. 31, 2018 | $ 3,429 | $ 1,309,215 | $ (602) | $ (4,090) | $ (1,959,982) | $ (101) | $ (652,131) | (652,131) | ||||||
| Balance, shares at Dec. 31, 2018 | 34,291,905 | 34,291,905 | ||||||||||||
| Beneficial conversion feature on convertible note | 125,000 | 125,000 | ||||||||||||
| Loss on foreign currency translation | 143,001 | 143,001 | ||||||||||||
| Net loss | $ (2,648,744) | (2,648,744) | ||||||||||||
| Balance at Jun. 30, 2019 | $ 74,074 | |||||||||||||
| Balance, shares at Jun. 30, 2019 | 39,922,899 |
| X | ||||||||||
- Definition Consolidation of additional paid in capital. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other increase (decrease) in additional paid in capital (APIC). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|